HIPEC After Initial CRS in Patients Who Have Received NACT

NCT03540017 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer
Fallopian Tube Cancer
Primary Peritoneal Carcinoma

Interventions

DRUG: Cisplatin

Sponsor

Northwell Health

Collaborators

[object Object]